Clearmind Medicine Inc. reported negative cash flows from operations and an accumulated deficit, raising substantial doubt about its ability to continue as a going concern.

US · 2026-09-10

1. Step 1 · The triggerClearmind Medicine Inc. discloses negative operating cash flows and an accumulated deficit, triggering a going-concern warning.
2. Step 2 · Knock-onThe going-concern warning raises Clearmind's cost of capital and restricts access to new funding, increasing the risk of operational cutbacks or default.
3. Step 3 · Reaches youUS SMEs with exposure to Clearmind face heightened counterparty risk, with increased likelihood of delayed payments or contract disruption.

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: SEC EDGAR — Current filings

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.